Week 35 M&A Roundup: Karman Holdings, Succession Capital & Valerio Therapeutics

Quick answer: three verified lower-middle-market acquisitions announced during Week 35 (August 24-30, 2026) — US defense manufacturer Karman Holdings’ ~$95M cash purchase of UK precision engineer Walker Precision, independent-sponsor Succession Capital’s $11M buyout of gift-wrap maker Jillson & Roberts, and Valerio Therapeutics’ EUR 30M acquisition of Belgian biotech eTheRNA Immunotherapies. All three are verified against a primary source.

Every deal is pulled directly from WhoBoughtWho’s tracked acquisition history, verified against its original source — no estimates presented as fact, no unsourced deals.

3 acquisitions from Week 35

Buyer spotlight: Karman Holdings

Who is Karman Holdings?

Karman Holdings is a US manufacturer of precision-engineered components and systems for the defense and space industries — the kind of specialized supplier that builds the sub-assemblies and structures larger prime contractors and space programs depend on. Precision manufacturing at defense-grade tolerances requires certifications, equipment, and institutional expertise that take years to build, which makes acquisition a faster route to capacity and capability than greenfield expansion.

Why buy a UK precision engineer

Walker Precision Engineering’s UK base gives Karman manufacturing capacity and customer relationships outside the US defense-industrial base — relevant both for serving UK/European defense and space programs directly and for diversifying supply chain geography, a consideration that’s become more strategically important across the defense sector generally as governments push for supply chain resilience and allied-nation sourcing. Karman’s own characterization of Walker’s technology as “highly complementary” suggests this is a capability extension rather than pure capacity addition — Walker likely brings specific technical expertise or certifications Karman’s existing US operations don’t already have.

Why fund it with term loan debt, not equity

Financing the ~$95M price through an increase in existing term loans rather than issuing new equity is a signal about how Karman views the deal’s risk and return profile. Debt financing is cheaper than equity when a company is confident the acquired business’s cash flows can service the additional debt service comfortably — using debt preserves existing shareholders’ ownership percentage rather than diluting them to raise fresh capital. For a defense-sector platform with government and prime-contractor revenue that tends to be relatively predictable and long-cycle, debt-funded bolt-on acquisitions like this one are a common and low-friction way to keep growing capacity without disrupting the cap table.

Deal tracker: Succession Capital and Jillson & Roberts

Jillson & Roberts closed on August 29, 2026 with a roughly half-senior-debt financing stack and a seven-party independent-sponsor syndicate, so the structure is worth a closer look.

What the deal name signals: succession, not distress

“Succession Capital” as an acquirer name is a useful hint about the deal type itself: this is a succession buyout, where a founder or founding family is exiting a business they built — often because there’s no next-generation family member ready or willing to take over — rather than a distressed sale or competitive strategic bidding process. Jillson & Roberts was founded in 1974, meaning the founding generation is now over 50 years into the business; that’s a very common trigger point for a succession-driven sale in family manufacturing businesses, and it typically means the acquirer is negotiating with a motivated but not desperate seller, at a fair rather than fire-sale price.

Reading the investor syndicate

The named backers — Novastone Partners US, Altis, Iberia, CapitalPad, South Highland Ventures (SHV ETA Fund I), plus individuals Dan Dorman and Pau Cortes — is a mix of institutional search-fund/independent-sponsor capital providers and named individual investors, financed roughly half with senior debt. That structure (multiple smaller equity checks plus a single bank or lender providing acquisition debt) is the standard independent-sponsor financing stack: no single equity investor takes outsized concentration risk in one $11M deal, while the debt piece is sized to what the target’s ~$2.4M EBITDA can comfortably service.

Why gift wrap and packaging fits this buyer profile

At over $11M in sales and $2.4M EBITDA, Jillson & Roberts sits squarely in the size range independent sponsors and search funds specialize in — too small to attract institutional private equity funds (whose minimum check sizes usually require deals several times this size to be worth the diligence effort) but large enough to support a full-time operator and service acquisition debt. Consumer packaging and gift products are also a category with durable, non-cyclical demand and long-standing customer relationships (retailers reordering the same SKUs annually), which reduces the post-acquisition execution risk that comes with categories dependent on winning new customers to hit the underwriting case.

---

WhoBoughtWho tracks acquisitions like these as they’re announced — browse the full acquisition history, explore the private equity and search fund directories, or subscribe to WhoBoughtWho Weekly for verified deals delivered every week.